Based on the important role of CD4+T cells in NASH initiation, progression, and NASH–HCC transition, the role of CD4+T cells in HCC immune checkpoint blockade efficiency warrants the acquisition of further evidence. This evidence concerns the gene CD4 and metabolic dysfunction-associated steatohepatitis.